dipyridamole has been researched along with Blood Pressure, High in 121 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess the value of dipyridamole-dobutamine stress echocardiography test (Dip-Dob SET) in detecting myocardial ischemia in hypertensive patients with chest pain and to compare it with the results of the dipyridamole-atropine stress echocardiography test (Dip-Atro SET)." | 9.11 | Dipyridamole-dobutamine stress echocardiography for the detection of myocardial ischemia in patients with hypertension. ( Marinkovic, J; Milosavljevic, J; Ostojic, M, 2005) |
| " The aim of the study was to compare the diagnostic value of exercise electrocardiography and dipyridamole stress echo in chest pain patients with right bundle branch block, and to verify whether stress testing accuracy is affected by history of hypertension." | 9.10 | Diagnostic value of exercise electrocardiography and dipyridamole stress echocardiography in hypertensive and normotensive chest pain patients with right bundle branch block. ( Baldini, U; Bigi, R; Cortigiani, L; Landi, P; Mariani, PR; Picano, E; Rigo, F, 2003) |
| "1), with left ventricular hypertrophy, typical angina pectoris, ischemia that can be induced by exercise-electrocardiography test, without previous myocardial infarction, myocardial revascularization or diabetes mellitus, underwent dipyridamole-echocardiography test, thallium exercise myocardial scintigraphy and coronarography." | 9.08 | [Dipyridamole-echocardiography and thallium exercise myocardial scintigraphy in the diagnosis of obstructive coronary or microvascular disease in hypertensive patients with left ventricular hypertrophy and angina]. ( Astarita, C; Gambardella, S; Liguori, E; Maresca, FS; Nicolai, E; Rumolo, S, 1998) |
| "In arterial hypertension, MBF during pacing tachycardia and after dipyridamole is impaired." | 9.08 | Comparative effects of enalapril and verapamil on myocardial blood flow in systemic hypertension. ( Gallopin, M; Giorgetti, A; L'Abbate, A; Marabotti, C; Neglia, D; Palombo, C; Parodi, O; Sambuceti, G; Simonetti, I, 1997) |
| "From 1976 to 1985, a total of 58 infants and children with the hemolytic-uremic syndrome were randomly assigned to treatment either with heparin and dipyridamole or with supportive management only." | 9.06 | Heparin plus dipyridamole in childhood hemolytic-uremic syndrome: a prospective, randomized study. ( Binda ki Muaka, P; Eeckels, R; Mercieca, V; Proesmans, W; Van Damme, B; Van Damme-Lombaerts, R; Vermylen, J; Vlietinck, R, 1988) |
| "A considerable proportion of patients discontinue dipyridamole therapy because of headache." | 7.75 | Risk indicators for development of headache during dipyridamole treatment after cerebral ischaemia of arterial origin. ( Algra, A; Halkes, PH; Kappelle, LJ; Koudstaal, PJ; van Gijn, J, 2009) |
| "The goal of this study was to examine the relationship between plasma asymmetric dimethylarginine (ADMA) level and hyperemic myocardial blood flow (MBF) in subjects with borderline hypertension (BHT) and familial hypercholesterolemia (FH)." | 7.71 | Plasma asymmetric dimethylarginine and hyperemic myocardial blood flow in young subjects with borderline hypertension or familial hypercholesterolemia. ( Knuuti, J; Laakso, J; Laaksonen, R; Laine, H; Päivä, H; Raitakari, OT, 2002) |
| "To assess the prognostic value of dipyridamole stress echocardiography (DET) for ischemic events in a subset of patients with hypertension with left ventricular hypertrophy, chest pain and resting electrocardiographic repolarization abnormalities." | 7.71 | Prognostic value of dipyridamole stress echocardiography in hypertensive patients with left ventricular hypertrophy, chest pain and resting electrocardiographic repolarization abnormalities. ( Agricola, E; Ammaturo, T; Ballo, P; Barbati, R; Focardi, M; Guerrini, F; Mondillo, S; Nami, R; Picchi, A, 2001) |
| "In 101 patients with hypertension, chest pain and positive exercise ECG, we performed stress/rest myocardial single photon emission computed tomography with 99mTc-MIBI, dipyridamole and dobutamine stress echocardiography and coronary angiography." | 7.70 | Comparison of stress/rest myocardial perfusion tomography, dipyridamole and dobutamine stress echocardiography for the detection of coronary disease in hypertensive patients with chest pain and positive exercise test. ( Chierchia, SL; Dabrowski, P; Fragasso, G; Lu, C; Pagnotta, P; Sheiban, I, 1999) |
| "The aim of this study is to try to evaluate the relationship between arterial hypertension and ischemic heart disease (IHD) in the light of the physiopathologic response pattern to the dipyridamole echocardiography test (DET) in hypertensive patients, in pharmacologic washout, without any electrocardiographic ST segment depression during exercise tests or at rest." | 7.69 | Hypertension and ischemic heart disease. Role of dipyridamole echocardiography test. ( Circo, AG; Doria, G; Gulizia, MM; Lo Giudice, P; Valenti, R, 1994) |
| "The non-invasive diagnosis of coronary artery disease in hypertensives with chest pain is an important clinical concern because all exercise-dependent tests display limited feasibility and diagnostic accuracy; by contrast, dipyridamole echocardiography testing has been shown to have a similar feasibility and accuracy in hypertensive and normotensive subjects." | 7.69 | Technetium-99m sestamibi myocardial tomography based on dipyridamole echocardiography testing in hypertensive patients with chest pain. ( Bossini, A; Cassone, R; Colella, AC; Danieli, R; Moroni, C; Schillaci, O; Scopinaro, F; Tavolaro, R, 1997) |
| "To assess the value of dipyridamole-dobutamine stress echocardiography test (Dip-Dob SET) in detecting myocardial ischemia in hypertensive patients with chest pain and to compare it with the results of the dipyridamole-atropine stress echocardiography test (Dip-Atro SET)." | 5.11 | Dipyridamole-dobutamine stress echocardiography for the detection of myocardial ischemia in patients with hypertension. ( Marinkovic, J; Milosavljevic, J; Ostojic, M, 2005) |
| " The aim of the study was to compare the diagnostic value of exercise electrocardiography and dipyridamole stress echo in chest pain patients with right bundle branch block, and to verify whether stress testing accuracy is affected by history of hypertension." | 5.10 | Diagnostic value of exercise electrocardiography and dipyridamole stress echocardiography in hypertensive and normotensive chest pain patients with right bundle branch block. ( Baldini, U; Bigi, R; Cortigiani, L; Landi, P; Mariani, PR; Picano, E; Rigo, F, 2003) |
| " Fourteen patients with essential hypertension were studied with coronary flow reserve and with transvenous endomyocardial biopsy before and after 12 months of antihypertensive treatment with perindopril (4 to 8 mg/d, mean 5." | 5.09 | Repair of coronary arterioles after treatment with perindopril in hypertensive heart disease. ( Brehm, M; Mundhenke, M; Schwartzkopff, B; Strauer, BE, 2000) |
| "Both combined dipyridamole and exercise protocols for scintigraphic myocardial single photon emission computed tomography in patients with hypertension are safe and increase heart rate without an excessive elevation in blood pressure." | 5.09 | Combined protocols for myocardial perfusion imaging in patients with hypertension. ( Batsakis, C; Christakopoulou, I; Ilias, I; Karidis, K; Panoutsopoulos, G; Petrou, A; Savari, E, 1999) |
| "1), with left ventricular hypertrophy, typical angina pectoris, ischemia that can be induced by exercise-electrocardiography test, without previous myocardial infarction, myocardial revascularization or diabetes mellitus, underwent dipyridamole-echocardiography test, thallium exercise myocardial scintigraphy and coronarography." | 5.08 | [Dipyridamole-echocardiography and thallium exercise myocardial scintigraphy in the diagnosis of obstructive coronary or microvascular disease in hypertensive patients with left ventricular hypertrophy and angina]. ( Astarita, C; Gambardella, S; Liguori, E; Maresca, FS; Nicolai, E; Rumolo, S, 1998) |
| "In arterial hypertension, MBF during pacing tachycardia and after dipyridamole is impaired." | 5.08 | Comparative effects of enalapril and verapamil on myocardial blood flow in systemic hypertension. ( Gallopin, M; Giorgetti, A; L'Abbate, A; Marabotti, C; Neglia, D; Palombo, C; Parodi, O; Sambuceti, G; Simonetti, I, 1997) |
| "In asymptomatic essential hypertensive patients with angiographically normal coronary arteries and without left ventricular hypertrophy, dipyridamole-induced ischemic-like ST segment depression may be a marker of coronary microvascular disease." | 5.08 | Presence of cardiovascular structural changes in essential hypertensive patients with coronary microvascular disease and effects of long-term treatment. ( Di Legge, V; Ghiadoni, L; Lucarini, A; Salvetti, A; Taddei, S; Virdis, A, 1996) |
| "From 1976 to 1985, a total of 58 infants and children with the hemolytic-uremic syndrome were randomly assigned to treatment either with heparin and dipyridamole or with supportive management only." | 5.06 | Heparin plus dipyridamole in childhood hemolytic-uremic syndrome: a prospective, randomized study. ( Binda ki Muaka, P; Eeckels, R; Mercieca, V; Proesmans, W; Van Damme, B; Van Damme-Lombaerts, R; Vermylen, J; Vlietinck, R, 1988) |
| "This study was aimed at evaluating whether transient dipyridamole-induced myocardial ischemia in hypertensive patients reflects on endothelin-1 plasma levels by comparing normotensives and hypertensives with or without stable angina." | 3.91 | Endothelin-1 in hypertensive patients with ischemic heart disease. ( Affricano, C; Bondanini, F; Cassone, R; Gaspardone, A; Gaudio, C; Moroni, C; Schillaci, O; Tolone, S, 2019) |
| "We enrolled 129 patients with true RHTN regularly followed in our specialty hypertension clinic and evaluated then by resting and dipyridamole pharmacological stress myocardial perfusion scintigraphy." | 3.81 | Predictors of silent myocardial ischemia in resistant hypertensive patients. ( Barbaro, NR; Calhoun, DA; de Faria, AP; Fontana, V; Modolo, R; Moreno, H; Nascimento, BB; Paganelli, MO; Ramos, CD; Sabbatini, AR, 2015) |
| "A considerable proportion of patients discontinue dipyridamole therapy because of headache." | 3.75 | Risk indicators for development of headache during dipyridamole treatment after cerebral ischaemia of arterial origin. ( Algra, A; Halkes, PH; Kappelle, LJ; Koudstaal, PJ; van Gijn, J, 2009) |
| "Twenty-three patients with angiographically diagnosed coronary artery disease (CAD) underwent B-mode ultrasound examination to measure their common carotid IMT and positron emission tomography (PET) with dipyridamole intervention to obtain their MFR." | 3.72 | Common carotid intima-media thickness is correlated with myocardial flow reserve in patients with coronary artery disease: a useful non-invasive indicator of coronary atherosclerosis. ( Aoyagi, T; Nagai, R; Sonoda, M; Takenaka, K; Yokoyama, I; Yonekura, K, 2004) |
| "To establish whether safety and feasibility of dobutamine and dipyridamole stress echocardiography are affected by history of hypertension." | 3.71 | Safety and feasibility of dobutamine and dipyridamole stress echocardiography in hypertensive patients. ( Bigi, R; Cortigiani, L; Desideri, A; Fiorentini, C; Nannini, E; Zanetti, L, 2002) |
| "The aims of the present study were: (a) to demonstrate whether quantitative myocardial contrast echocardiography can detect the increase in coronary flow induced by dipyridamole infusion vasodilation through the myocardial opacification due to the transit of microbubbles, both at rest and after dipyridamole induced vasodilation; (b) to explore the coronary microcirculatory function before and after dipyridamole in two different models: asymptomatic and relatively young hypertensive patients with a mild degree of left ventricular hypertrophy, and healthy controls." | 3.71 | Coronary microcirculation in essential hypertension: a quantitative myocardial contrast echocardiographic approach. ( Bertini, A; Dell'Omo, G; Di Bello, V; Giorgi, D; Mariani, M; Mengozzi, G; Nardi, C; Palagi, C; Paterni, M; Pedrinelli, R; Talini, E, 2002) |
| "One hundred twenty-five patients (60 +/- 10 years old, 60 women) with known (35, previous myocardial infarction) or suspected (90) coronary artery disease (CAD) and no more than 50% coronary stenoses underwent pharmacologic (48 dipyridamole and 77 dobutamine) stress echocardiography (SE) and prospective follow-up (36 +/- 22 months) for cardiac death, nonfatal infarction, and unstable angina." | 3.71 | Stress echocardiography for risk stratification of patients with chest pain and normal or slightly narrowed coronary arteries. ( Bax, JJ; Bigi, R; Colombo, P; Cortigiani, L; Desideri, A; Fiorentini, C; Sponzilli, C, 2002) |
| "To assess the prognostic value of dipyridamole stress echocardiography (DET) for ischemic events in a subset of patients with hypertension with left ventricular hypertrophy, chest pain and resting electrocardiographic repolarization abnormalities." | 3.71 | Prognostic value of dipyridamole stress echocardiography in hypertensive patients with left ventricular hypertrophy, chest pain and resting electrocardiographic repolarization abnormalities. ( Agricola, E; Ammaturo, T; Ballo, P; Barbati, R; Focardi, M; Guerrini, F; Mondillo, S; Nami, R; Picchi, A, 2001) |
| "The goal of this study was to examine the relationship between plasma asymmetric dimethylarginine (ADMA) level and hyperemic myocardial blood flow (MBF) in subjects with borderline hypertension (BHT) and familial hypercholesterolemia (FH)." | 3.71 | Plasma asymmetric dimethylarginine and hyperemic myocardial blood flow in young subjects with borderline hypertension or familial hypercholesterolemia. ( Knuuti, J; Laakso, J; Laaksonen, R; Laine, H; Päivä, H; Raitakari, OT, 2002) |
| "Myocardial blood flow was measured at baseline and during dipyridamole-induced hyperemia by means of positron emission tomography and oxygen-15-labeled water in asymptomatic young men with borderline hypertension (group 1: n = 16, mean +/- SD age 37 +/- 4 years, 24-h ambulatory blood pressure 135 +/- 10/81 +/- 9 mm Hg) and matched healthy control subjects (group 2: n = 19, age 35 +/- 3 years, 24-h ambulatory blood pressure 119 +/- 8/69 +/- 8 mm Hg, p < 0." | 3.70 | Early impairment of coronary flow reserve in young men with borderline hypertension. ( Iida, H; Knuuti, J; Laine, H; Niinikoski, H; Nuutila, P; Pitkänen, OP; Raitakari, OT; Viikari, J, 1998) |
| "In 101 patients with hypertension, chest pain and positive exercise ECG, we performed stress/rest myocardial single photon emission computed tomography with 99mTc-MIBI, dipyridamole and dobutamine stress echocardiography and coronary angiography." | 3.70 | Comparison of stress/rest myocardial perfusion tomography, dipyridamole and dobutamine stress echocardiography for the detection of coronary disease in hypertensive patients with chest pain and positive exercise test. ( Chierchia, SL; Dabrowski, P; Fragasso, G; Lu, C; Pagnotta, P; Sheiban, I, 1999) |
| " Moreover, patients without any history of coronary heart disease and showing a normal resting ECG underwent a bicycle exercise test or a dipyridamole thallium scintigraphy to detect possible silent myocardial ischemia." | 3.69 | Macrovascular disease is associated with increased plasma apolipoprotein A-IV levels in NIDDM. ( Brun, JM; Cohen, M; Gambert, P; Lagrost, L; Petit, JM; Vaillant, G; Vergès, BL, 1997) |
| "The non-invasive diagnosis of coronary artery disease in hypertensives with chest pain is an important clinical concern because all exercise-dependent tests display limited feasibility and diagnostic accuracy; by contrast, dipyridamole echocardiography testing has been shown to have a similar feasibility and accuracy in hypertensive and normotensive subjects." | 3.69 | Technetium-99m sestamibi myocardial tomography based on dipyridamole echocardiography testing in hypertensive patients with chest pain. ( Bossini, A; Cassone, R; Colella, AC; Danieli, R; Moroni, C; Schillaci, O; Scopinaro, F; Tavolaro, R, 1997) |
| "The aim of this study is to try to evaluate the relationship between arterial hypertension and ischemic heart disease (IHD) in the light of the physiopathologic response pattern to the dipyridamole echocardiography test (DET) in hypertensive patients, in pharmacologic washout, without any electrocardiographic ST segment depression during exercise tests or at rest." | 3.69 | Hypertension and ischemic heart disease. Role of dipyridamole echocardiography test. ( Circo, AG; Doria, G; Gulizia, MM; Lo Giudice, P; Valenti, R, 1994) |
| "In 14 patients (10 men and 4 women) with arterial hypertension and 8 normotensive subjects, minimal coronary resistance and vasodilator reserve (dipyridamole: 0." | 3.68 | Structural and functional alterations of the intramyocardial coronary arterioles in patients with arterial hypertension. ( Frenzel, H; Knauer, S; Motz, W; Schwartzkopff, B; Strauer, BE; Vogt, M, 1993) |
| " The transient dyssynergy detected by two-dimensional echocardiography and evoked during dipyridamole infusion is a marker of coronary disease that is equally reliable in normotensive and hypertensive individuals." | 3.68 | Dipyridamole echocardiography stress testing in hypertensive patients. Targets and tools. ( Camici, P; L'Abbate, A; Lattanzi, F; Lucarini, AR; Marini, C; Picano, E; Salvetti, A, 1991) |
| "Results of recent clinical trials on secondary prevention of ischemic heart disease indicate that judicious, long-term administration of adrenergic beta blockers and platelet-active drugs such as aspirin and Persantine (dipyridamole) would seem to yield protection against mortality associated with acute myocardial infarction, including sudden death." | 3.67 | Clinical trials on the efficacy of pharmacologic intervention reducing mortality from cardiovascular diseases. ( Borhani, NO, 1985) |
| "With carvedilol treatment, LVMI was lower (p<0." | 2.75 | Effect of carvedilol on coronary flow reserve in patients with hypertensive left-ventricular hypertrophy. ( Mei, Z; Xiaozhen, H; Yu, S; Yun, Z, 2010) |
| "Stroke is a major cause of morbidity and mortality." | 2.41 | A benefit-risk assessment of agents used in the secondary prevention of stroke. ( MacWalter, RS; Shirley, CP, 2002) |
| "Hypertension may affect CFR independently of obstructive coronary artery disease (CAD) through coronary microcirculatory damage." | 1.37 | Diagnostic and prognostic value of Doppler echocardiographic coronary flow reserve in the left anterior descending artery in hypertensive and normotensive patients [corrected].. ( Bovenzi, F; Cortigiani, L; Galderisi, M; Gherardi, S; Picano, E; Rigo, F; Sicari, R, 2011) |
| "An all the patients with left ventricular hypertrophy (LVH) had decreased CFVR whose values with the myocardial mass index above 130 g/m2 were significantly less than those in the absence of LVH." | 1.32 | [Coronary flow vasodilator reserve in patients with type 2 diabetes mellitus-associated arterial hypertension]. ( Efimova, EV; Karpov, RS; Koshel'skaia, OA; Ocheredko, NA; Panafidin, AV; Soldatenko, MV, 2004) |
| "The baseline MBF was comparable among NIDDM patients with microvascular angina, NIDDM patients with CAD, and control subjects." | 1.31 | Coronary microangiopathy in type 2 diabetic patients: relation to glycemic control, sex, and microvascular angina rather than to coronary artery disease. ( Nagai, R; Ohtake, T; Ohtomo, K; Shin, WS; Yamada, N; Yang, W; Yokoyama, I; Yonekura, K, 2000) |
| "A clinical diagnosis of thrombotic thrombocytopenic purpura (TTP) was made." | 1.30 | A case of dermatomyositis complicated by thrombotic thrombocytopenic purpura. ( Arase, S; Horie, T; Miyaoka, Y; Nameda, Y; Sano, N; Shigekiyo, T; Urano, Y, 1997) |
| "The effect of left ventricular hypertrophy on regional vasodilating coronary capability in arterial hypertension is controversial, and no quantitative method has been applied to assess a possible correlation." | 1.30 | Homogeneously reduced versus regionally impaired myocardial blood flow in hypertensive patients: two different patterns of myocardial perfusion associated with degree of hypertrophy. ( Bigalli, G; Gimelli, A; Giorgetti, A; Neglia, D; Parodi, G; Parodi, O; Pedrinelli, R; Sambuceti, G; Schneider-Eicke, J, 1998) |
| "A coronary heart disease was diagnosed by coronarography in 10 patients (4." | 1.29 | [Diagnostic value of myocardial thallium stress scintigraphy in the detection of coronary artery disease in patients undergoing chronic hemodialysis]. ( Aubry, N; Dahan, M; Faraggi, M; Gourgon, R; Himbert, D; Legallicier, B; Mignon, F; Siohan, P; Viron, B, 1995) |
| "Hypertension is common in patients undergoing stress and delayed single-photon emission computed tomography (SPECT) thallium-201 myocardial perfusion imaging." | 1.29 | Absence of defects in SPECT thallium-201 myocardial images in patients with systemic hypertension and left ventricular hypertrophy. ( Cecil, MP; Chu, TH; Eisner, RL; Merlino, JD; Patterson, RE; Pilcher, WC, 1994) |
| "Arterial hypertension is the most common cause of congestive heart failure and an important risk factor in coronary artery disease (CAD)." | 1.28 | Coronary circulation in arterial hypertension. ( Motz, W; Scheler, S; Schwartzkopff, B; Strauer, BE; Vogt, M, 1991) |
| "Hypertension was equally common in the two groups, but tended to be less well controlled in the epistaxis patients compared to the controls." | 1.28 | Drug-induced epistaxis? ( Shenoi, PM; Watson, MG, 1990) |
| "Dipyridamole was infused intravenously at a rate of 0." | 1.27 | [Reverse redistribution in dipyridamole-loading thallium-201 images using single photon emission computed tomography]. ( Bunko, H; Masuda, M; Mori, K, 1986) |
| "Cardiac hypertrophy is associated with a decrease in coronary reserve." | 1.26 | Effects of duration and severity of arterial hypertension and cardiac hypertrophy on coronary vasodilator reserve. ( Marcus, ML; Peters, KG; Tomanek, RJ; Wangler, RD, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 37 (30.58) | 18.7374 |
| 1990's | 45 (37.19) | 18.2507 |
| 2000's | 31 (25.62) | 29.6817 |
| 2010's | 6 (4.96) | 24.3611 |
| 2020's | 2 (1.65) | 2.80 |
| Authors | Studies |
|---|---|
| Alexanderson-Rosas, E | 1 |
| Garcia-Cardenas, M | 1 |
| Gonzalez-Hernandez, M | 1 |
| Keirns, C | 1 |
| Carvajal-Juarez, I | 1 |
| Espinola-Zavaleta, N | 1 |
| Evangelou, D | 1 |
| Bechlioulis, A | 1 |
| Tzeltzes, G | 1 |
| Lakkas, L | 1 |
| Theodorou, I | 1 |
| Kalaitzidis, R | 1 |
| Dounousi, E | 1 |
| Michalis, LK | 1 |
| Naka, KK | 1 |
| Moroni, C | 2 |
| Tolone, S | 1 |
| Bondanini, F | 1 |
| Schillaci, O | 2 |
| Affricano, C | 1 |
| Cassone, R | 2 |
| Gaspardone, A | 1 |
| Gaudio, C | 1 |
| Nawathe, A | 1 |
| Ariyarajah, V | 1 |
| Apiyasawat, S | 1 |
| Barac, I | 1 |
| Spodick, DH | 1 |
| Modolo, R | 1 |
| de Faria, AP | 1 |
| Paganelli, MO | 1 |
| Sabbatini, AR | 1 |
| Barbaro, NR | 1 |
| Nascimento, BB | 1 |
| Ramos, CD | 1 |
| Fontana, V | 1 |
| Calhoun, DA | 1 |
| Moreno, H | 1 |
| Gimelli, A | 2 |
| Marzullo, P | 1 |
| L'Abbate, A | 8 |
| Rovai, D | 1 |
| Halkes, PH | 1 |
| van Gijn, J | 1 |
| Kappelle, LJ | 1 |
| Koudstaal, PJ | 1 |
| Algra, A | 1 |
| Xiaozhen, H | 1 |
| Yun, Z | 1 |
| Mei, Z | 1 |
| Yu, S | 1 |
| Lu, C | 2 |
| Lu, F | 1 |
| Fragasso, G | 3 |
| Dabrowski, P | 2 |
| Di Bello, V | 3 |
| Chierchia, SL | 2 |
| Gianolli, L | 1 |
| Marzilli, M | 1 |
| Balbarini, A | 1 |
| Cortigiani, L | 6 |
| Rigo, F | 2 |
| Galderisi, M | 2 |
| Gherardi, S | 1 |
| Bovenzi, F | 1 |
| Picano, E | 8 |
| Sicari, R | 1 |
| Pedrinelli, R | 3 |
| Giorgi, D | 2 |
| Bertini, A | 1 |
| Talini, E | 2 |
| Mengozzi, G | 1 |
| Palagi, C | 2 |
| Nardi, C | 2 |
| Dell'Omo, G | 2 |
| Paterni, M | 2 |
| Mariani, M | 2 |
| de Simone, G | 1 |
| Zanetti, L | 1 |
| Bigi, R | 5 |
| Desideri, A | 4 |
| Fiorentini, C | 3 |
| Nannini, E | 1 |
| MacWalter, RS | 1 |
| Shirley, CP | 1 |
| Päivä, H | 1 |
| Laakso, J | 1 |
| Laine, H | 2 |
| Laaksonen, R | 1 |
| Knuuti, J | 2 |
| Raitakari, OT | 2 |
| Bax, JJ | 2 |
| Colombo, P | 1 |
| Sponzilli, C | 1 |
| Coletta, C | 1 |
| Amici, E | 1 |
| Odoguardi, L | 1 |
| Delle Donne, MG | 1 |
| KOBAYASHI, T | 1 |
| TAKEUCHI, M | 1 |
| KOENIG, E | 1 |
| TREPEL, F | 1 |
| Landi, P | 1 |
| Baldini, U | 1 |
| Mariani, PR | 1 |
| Sonoda, M | 1 |
| Yonekura, K | 3 |
| Yokoyama, I | 3 |
| Takenaka, K | 1 |
| Nagai, R | 2 |
| Aoyagi, T | 2 |
| Yamagata, K | 1 |
| Ichinose, S | 1 |
| Tagami, M | 1 |
| Karpov, RS | 1 |
| Koshel'skaia, OA | 1 |
| Soldatenko, MV | 1 |
| Efimova, EV | 1 |
| Ocheredko, NA | 1 |
| Panafidin, AV | 1 |
| Nemes, A | 1 |
| Neu, K | 1 |
| Forster, T | 1 |
| Kovacs, Z | 1 |
| Csanady, M | 1 |
| Milosavljevic, J | 1 |
| Ostojic, M | 1 |
| Marinkovic, J | 1 |
| Kjaer, A | 1 |
| Meyer, C | 1 |
| Wachtell, K | 1 |
| Olsen, MH | 1 |
| Ibsen, H | 1 |
| Opie, L | 1 |
| Holm, S | 1 |
| Hesse, B | 1 |
| Lacourcière, Y | 1 |
| Côté, C | 1 |
| Lefebvre, J | 1 |
| Dumont, M | 1 |
| Moir, TW | 1 |
| DeBra, DW | 1 |
| Marshall, AJ | 1 |
| Heidrich, H | 1 |
| Hinton, RC | 1 |
| Wangler, RD | 1 |
| Peters, KG | 1 |
| Marcus, ML | 1 |
| Tomanek, RJ | 2 |
| Bollinger, A | 1 |
| Biland, L | 1 |
| Brunner, U | 1 |
| Kappert, A | 1 |
| Krähenbühl, B | 1 |
| Mahler, F | 1 |
| Monti, M | 1 |
| Nachbur, B | 1 |
| Schneider, E | 1 |
| Widmer, LK | 1 |
| Opherk, D | 1 |
| Mall, G | 1 |
| Zebe, H | 1 |
| Schwarz, F | 1 |
| Weihe, E | 1 |
| Manthey, J | 1 |
| Kübler, W | 1 |
| Förster, W | 1 |
| Plastinina, RA | 1 |
| Logacheva, IV | 1 |
| Barenbaum, ES | 1 |
| Nikolaeva, VA | 1 |
| Polishchuk, MA | 1 |
| Yatsu, FM | 1 |
| Francini, D | 1 |
| Abbate, R | 1 |
| Seo, H | 1 |
| Chikamori, T | 1 |
| Yabe, T | 1 |
| Akagi, N | 1 |
| Ozawa, T | 1 |
| Doi, YL | 1 |
| Czernin, J | 1 |
| Barnard, RJ | 1 |
| Sun, KT | 1 |
| Krivokapich, J | 1 |
| Nitzsche, E | 1 |
| Dorsey, D | 1 |
| Phelps, ME | 1 |
| Schelbert, HR | 1 |
| Okumoto, S | 1 |
| Morita, H | 1 |
| Hirabayashi, K | 1 |
| Mizushige, K | 1 |
| Matsuo, H | 1 |
| Gulizia, MM | 1 |
| Lo Giudice, P | 1 |
| Doria, G | 1 |
| Valenti, R | 1 |
| Circo, AG | 1 |
| Cecil, MP | 1 |
| Pilcher, WC | 1 |
| Eisner, RL | 1 |
| Chu, TH | 1 |
| Merlino, JD | 1 |
| Patterson, RE | 1 |
| Barlow, PA | 1 |
| Connell, PM | 1 |
| Chen, Y | 1 |
| Torry, RJ | 1 |
| Schwartzkopff, B | 3 |
| Motz, W | 3 |
| Frenzel, H | 1 |
| Vogt, M | 2 |
| Knauer, S | 1 |
| Strauer, BE | 5 |
| Hegedüs, K | 1 |
| Fekete, I | 1 |
| Molnár, L | 1 |
| Rogov, VA | 1 |
| Tareeva, IE | 1 |
| Sidorova, IS | 1 |
| Androsova, SO | 1 |
| Katamadze, KT | 1 |
| Nikiforova, OV | 1 |
| Dahan, M | 1 |
| Legallicier, B | 1 |
| Himbert, D | 1 |
| Faraggi, M | 1 |
| Aubry, N | 1 |
| Siohan, P | 1 |
| Viron, B | 1 |
| Gourgon, R | 1 |
| Mignon, F | 1 |
| Chen, D | 1 |
| Lin, J | 1 |
| Chen, J | 1 |
| Virdis, A | 1 |
| Ghiadoni, L | 1 |
| Lucarini, A | 1 |
| Di Legge, V | 2 |
| Taddei, S | 2 |
| Salvetti, A | 7 |
| Cannon, RO | 1 |
| Shimonagata, T | 1 |
| Nanto, S | 1 |
| Hori, M | 1 |
| Ohara, T | 1 |
| Kim, Y | 1 |
| Takano, Y | 1 |
| Sakamoto, K | 1 |
| Kamado, K | 1 |
| Kubori, S | 1 |
| Kusuoka, H | 1 |
| Nishimura, T | 1 |
| Vergès, BL | 1 |
| Lagrost, L | 1 |
| Vaillant, G | 1 |
| Petit, JM | 1 |
| Cohen, M | 1 |
| Gambert, P | 1 |
| Brun, JM | 1 |
| Miyaoka, Y | 1 |
| Urano, Y | 1 |
| Nameda, Y | 1 |
| Shigekiyo, T | 1 |
| Horie, T | 1 |
| Sano, N | 1 |
| Arase, S | 1 |
| Kozàkovà, M | 1 |
| Palombo, C | 2 |
| Pratali, L | 1 |
| Pittella, G | 1 |
| Galetta, F | 1 |
| Scopinaro, F | 1 |
| Tavolaro, R | 1 |
| Danieli, R | 1 |
| Bossini, A | 1 |
| Colella, AC | 1 |
| Parodi, O | 2 |
| Neglia, D | 2 |
| Sambuceti, G | 2 |
| Giorgetti, A | 2 |
| Marabotti, C | 1 |
| Gallopin, M | 1 |
| Simonetti, I | 1 |
| Schneider-Eicke, J | 1 |
| Bigalli, G | 1 |
| Parodi, G | 1 |
| Niinikoski, H | 1 |
| Pitkänen, OP | 1 |
| Iida, H | 1 |
| Viikari, J | 1 |
| Nuutila, P | 1 |
| Puranen, J | 1 |
| Laakso, M | 1 |
| Riekkinen, PJ | 1 |
| Sivenius, J | 1 |
| Astarita, C | 2 |
| Nicolai, E | 2 |
| Liguori, E | 1 |
| Gambardella, S | 1 |
| Rumolo, S | 1 |
| Maresca, FS | 2 |
| Kuriyama, S | 1 |
| Tomonari, H | 1 |
| Hosoya, T | 1 |
| Vanzetto, G | 1 |
| Halimi, S | 1 |
| Hammoud, T | 1 |
| Fagret, D | 1 |
| Benhamou, PY | 1 |
| Cordonnier, D | 1 |
| Denis, B | 1 |
| Machecourt, J | 1 |
| Momomura, S | 1 |
| Ohtake, T | 2 |
| Yang, W | 2 |
| Kobayakawa, N | 1 |
| Sugiura, S | 1 |
| Yamada, N | 2 |
| Ohtomo, K | 2 |
| Sasaki, Y | 1 |
| Omata, M | 1 |
| Yazaki, Y | 1 |
| Pagnotta, P | 1 |
| Sheiban, I | 1 |
| Panoutsopoulos, G | 1 |
| Savari, E | 1 |
| Ilias, I | 1 |
| Batsakis, C | 1 |
| Petrou, A | 1 |
| Karidis, K | 1 |
| Christakopoulou, I | 1 |
| Yamada, M | 1 |
| Omata, K | 1 |
| Abe, F | 1 |
| Ito, S | 1 |
| Abe, K | 1 |
| Stakhovskaia, LV | 1 |
| Kvasova, OV | 1 |
| Prianikova, NA | 1 |
| Efremova, NM | 1 |
| Skvortsova, VI | 1 |
| Joubert, J | 1 |
| McLean, CA | 1 |
| Reid, CM | 1 |
| Davel, D | 1 |
| Pilloy, W | 1 |
| Delport, R | 1 |
| Steyn, L | 1 |
| Walker, AR | 1 |
| Shin, WS | 1 |
| Hamouda, MS | 1 |
| Kassem, HK | 1 |
| Salama, M | 1 |
| El Masry, M | 1 |
| Shaaban, N | 1 |
| Sadek, E | 1 |
| Khandheria, BK | 1 |
| Seward, JB | 1 |
| Elhendy, A | 1 |
| Brehm, M | 1 |
| Mundhenke, M | 1 |
| Masuda, D | 1 |
| Nohara, R | 1 |
| Tamaki, N | 1 |
| Hosokawa, R | 1 |
| Inada, H | 1 |
| Hikai, T | 1 |
| Chen, LG | 1 |
| Tadamura, E | 1 |
| Kudou, T | 1 |
| Konishi, J | 1 |
| Fujita, M | 1 |
| Sasayama, S | 1 |
| Pálinkás, A | 1 |
| Varga, A | 1 |
| Mondillo, S | 1 |
| Agricola, E | 1 |
| Ammaturo, T | 1 |
| Guerrini, F | 1 |
| Barbati, R | 1 |
| Focardi, M | 1 |
| Picchi, A | 1 |
| Ballo, P | 1 |
| Nami, R | 1 |
| Celegon, L | 1 |
| Beache, GM | 1 |
| Herzka, DA | 1 |
| Boxerman, JL | 1 |
| Post, WS | 1 |
| Gupta, SN | 1 |
| Faranesh, AZ | 1 |
| Solaiyappan, M | 1 |
| Bottomley, PA | 1 |
| Weiss, JL | 1 |
| Shapiro, EP | 1 |
| Hill, MN | 1 |
| Arcidiacono, G | 1 |
| Privitelli, L | 1 |
| Laurenti, A | 1 |
| Vicari, E | 1 |
| Conticello, A | 1 |
| Di Mauro, C | 1 |
| Quartarone, D | 1 |
| Di Mauro, M | 1 |
| Terranova, R | 1 |
| Alakhras, M | 1 |
| Baldari, D | 1 |
| El-Sherif, N | 1 |
| Turitto, G | 1 |
| McGiff, JC | 1 |
| O'Sullivan, DJ | 1 |
| Lim, GH | 1 |
| Darveniza, P | 1 |
| Coffey, GL | 1 |
| Bonnar, J | 2 |
| Redman, CW | 2 |
| Sheppard, BL | 1 |
| Browder, A | 1 |
| Browder, J | 1 |
| Modica, G | 1 |
| Ferrante, R | 1 |
| Howie, PW | 1 |
| Prentice, CR | 1 |
| Forbes, CD | 1 |
| Dubov, PB | 1 |
| Koniaeva, EB | 1 |
| Ostroumov, VB | 1 |
| Sergienko, VB | 1 |
| Iurenev, AP | 1 |
| Hirose, S | 1 |
| Yamada, A | 1 |
| Kasugai, M | 1 |
| Ishizuka, T | 1 |
| Tomoda, Y | 1 |
| Prisant, LM | 2 |
| von Dohlen, TW | 2 |
| Houghton, JL | 3 |
| Carr, AA | 3 |
| Frank, MJ | 3 |
| Gordge, MP | 1 |
| Rylance, PB | 1 |
| Neild, GH | 1 |
| Lucarini, AR | 5 |
| Bongiorni, MG | 1 |
| Lattanzi, F | 5 |
| Marini, C | 3 |
| Paperini, L | 1 |
| Scheler, S | 1 |
| Arzilli, F | 1 |
| Arrighi, P | 1 |
| Ena, IaM | 1 |
| Didkovskaia, LA | 1 |
| Camici, P | 1 |
| Persson, MG | 1 |
| Ohlén, A | 1 |
| Lindbom, L | 1 |
| Hedqvist, P | 1 |
| Gustafsson, LE | 1 |
| Nesto, RW | 1 |
| Watson, FS | 1 |
| Kowalchuk, GJ | 1 |
| Zarich, SW | 1 |
| Hill, T | 1 |
| Lewis, SM | 1 |
| Lane, SE | 1 |
| Watson, MG | 1 |
| Shenoi, PM | 1 |
| Distante, A | 3 |
| Clozel, JP | 1 |
| Hefti, F | 1 |
| Hachicha, J | 1 |
| Ammous, A | 1 |
| Damak, J | 1 |
| Hammami, M | 1 |
| Ghorbel, A | 1 |
| Rekik, S | 1 |
| Jarraya, A | 1 |
| Borhani, NO | 2 |
| De Prisco, F | 1 |
| DePuey, EG | 1 |
| Guertler-Krawczynska, E | 1 |
| Perkins, JV | 1 |
| Robbins, WL | 1 |
| Whelchel, JD | 1 |
| Clements, SD | 1 |
| Van Damme-Lombaerts, R | 1 |
| Proesmans, W | 1 |
| Van Damme, B | 1 |
| Eeckels, R | 1 |
| Binda ki Muaka, P | 1 |
| Mercieca, V | 1 |
| Vlietinck, R | 1 |
| Vermylen, J | 1 |
| Mori, K | 1 |
| Masuda, M | 1 |
| Bunko, H | 1 |
| Vinichuk, SM | 1 |
| Littler, WA | 1 |
| Beilin, LJ | 1 |
| Lee, Gde J | 1 |
| Friedman, A | 1 |
| Kincaid-Smith, P | 1 |
| Bologna, E | 1 |
| Osugi, S | 1 |
| Danta, G | 1 |
| Itatsu, H | 1 |
| Schmitt, G | 1 |
| Hauss, W | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Mineralocorticoid Receptor, Coronary Microvascular Function, and Cardiac Efficiency in Hypertension[NCT05593055] | Phase 4 | 75 participants (Anticipated) | Interventional | 2023-08-25 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
8 reviews available for dipyridamole and Blood Pressure, High
| Article | Year |
|---|---|
Hypertensive response to dipyridamole: Report of a case and review of the literature.
Topics: Dipyridamole; Humans; Hypertension; Vasodilator Agents | 2023 |
A benefit-risk assessment of agents used in the secondary prevention of stroke.
Topics: Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Antihypertensive Agents; Aspirin; Clinical | 2002 |
Drug therapy of hypertension and ischaemic heart disease.
Topics: Adrenergic beta-Antagonists; Adult; Angina Pectoris; Antihypertensive Agents; Aspirin; Clofibrate; C | 1981 |
[Peripheral arterial occlusions. Principles, possibilities and limits of conservative therapy].
Topics: Ancrod; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Cardiomyopathies; Dextrans; Digitalis | 1981 |
The heart in hypertension. Thinking small.
Topics: Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Animals; Coronary Circulation; Dipyridamo | 1996 |
Diagnosing coronary artery disease in patients with hypertension: a resolved dilemma?
Topics: Cardiotonic Agents; Coronary Angiography; Coronary Disease; Diagnosis, Differential; Dipyridamole; D | 2000 |
[Quantitative determination of coronary reserve in diagnosis of coronary circulatory disorders].
Topics: Adrenergic beta-Antagonists; Cardiomegaly; Cardiomyopathies; Collagen Diseases; Coronary Circulation | 1977 |
Prostaglandins in circulatory disorders.
Topics: Angiotensin II; Antihypertensive Agents; Arachidonic Acids; Arteriosclerosis; Aspirin; Blood Platele | 1979 |
16 trials available for dipyridamole and Blood Pressure, High
| Article | Year |
|---|---|
Effect of carvedilol on coronary flow reserve in patients with hypertensive left-ventricular hypertrophy.
Topics: Administration, Sublingual; Adrenergic beta-Antagonists; Aged; Blood Flow Velocity; Blood Pressure; | 2010 |
Diagnostic value of exercise electrocardiography and dipyridamole stress echocardiography in hypertensive and normotensive chest pain patients with right bundle branch block.
Topics: Aged; Bundle-Branch Block; Chest Pain; Coronary Angiography; Coronary Disease; Dipyridamole; Echocar | 2003 |
Dipyridamole-dobutamine stress echocardiography for the detection of myocardial ischemia in patients with hypertension.
Topics: Dipyridamole; Dobutamine; Echocardiography; Exercise Test; Humans; Hypertension; Image Enhancement; | 2005 |
[Latent impairment of left ventricular filling in hypertension without left ventricular hypertrophy and improvement by dipyridamole treatment: pulsed Doppler echocardiography study].
Topics: Adult; Aged; Diastole; Dipyridamole; Echocardiography, Doppler, Pulsed; Exercise Test; Female; Human | 1995 |
[Acetylsalicylic acid and kurantil in the prevention of pregnancy complications in glomerulonephritis and hypertension].
Topics: Abortion, Spontaneous; Analysis of Variance; Aspirin; Chronic Disease; Dipyridamole; Drug Therapy, C | 1993 |
Improvement of coronary flow reserve after long-term therapy with enalapril.
Topics: Aged; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cardiomyopathy, Hyp | 1996 |
Presence of cardiovascular structural changes in essential hypertensive patients with coronary microvascular disease and effects of long-term treatment.
Topics: Acetylcholine; Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Coronary Circulation; Dip | 1996 |
Comparative effects of enalapril and verapamil on myocardial blood flow in systemic hypertension.
Topics: Antihypertensive Agents; Calcium Channel Blockers; Cardiac Pacing, Artificial; Coronary Circulation; | 1997 |
Efficacy of antiplatelet treatment in hypertensive patients with TIA or stroke.
Topics: Aspirin; Blood Pressure; Cerebrovascular Disorders; Dipyridamole; Double-Blind Method; Drug Therapy, | 1998 |
[Dipyridamole-echocardiography and thallium exercise myocardial scintigraphy in the diagnosis of obstructive coronary or microvascular disease in hypertensive patients with left ventricular hypertrophy and angina].
Topics: Adult; Aged; Angina Pectoris; Cardiomyopathy, Hypertrophic; Coronary Disease; Dipyridamole; Echocard | 1998 |
Combined protocols for myocardial perfusion imaging in patients with hypertension.
Topics: Adult; Combined Modality Therapy; Coronary Disease; Dipyridamole; Exercise Test; Female; Hand Streng | 1999 |
[The administration of dipyridamole (curantil) for the secondary prevention of ischemic stroke].
Topics: Acute Disease; Aged; Brain; Brain Ischemia; Dipyridamole; Dose-Response Relationship, Drug; Female; | 2000 |
Repair of coronary arterioles after treatment with perindopril in hypertensive heart disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Arterioles; Blood Pressure; Coronary Circulation; Coronary | 2000 |
[Clinical and hemostatic evaluation of curantyl in hypertensives].
Topics: Adult; Blood Coagulation; Dipyridamole; Drug Evaluation; Fibrinolysis; Hemostasis; Humans; Hypertens | 1991 |
Prevention of coronary heart disease in practice. Implications of the results of recent clinical trials.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina, Unstable; Aspirin; Blood Platelets; Cholesterol; C | 1985 |
Heparin plus dipyridamole in childhood hemolytic-uremic syndrome: a prospective, randomized study.
Topics: Adolescent; Anuria; Child; Child, Preschool; Dipyridamole; Drug Therapy, Combination; Female; Hemoly | 1988 |
97 other studies available for dipyridamole and Blood Pressure, High
| Article | Year |
|---|---|
Myocardial strain indices and coronary flow reserve are only mildly affected in healthy hypertensive patients.
Topics: Adult; Aged; Arterial Pressure; Blood Flow Velocity; Case-Control Studies; Coronary Circulation; Dip | 2021 |
Endothelin-1 in hypertensive patients with ischemic heart disease.
Topics: Adult; Dipyridamole; Echocardiography; Endothelin-1; Female; Humans; Hypertension; Male; Middle Aged | 2019 |
Correlation of echocardiographic left atrial abnormality with myocardial ischemia during myocardial perfusion assessment in the presence of known left ventricular hypertrophy.
Topics: Aged; Aged, 80 and over; Comorbidity; Coronary Artery Disease; Coronary Circulation; Diastole; Dipyr | 2013 |
Predictors of silent myocardial ischemia in resistant hypertensive patients.
Topics: Adult; Aged; Albuminuria; Antihypertensive Agents; Asymptomatic Diseases; Blood Pressure; Blood Pres | 2015 |
'False-positive' myocardial perfusion imaging: correlation with cardiovascular risk factors and effect on event-free survival.
Topics: Aged; Angina Pectoris; Coronary Circulation; Diabetes Mellitus; Dipyridamole; Electrocardiography; E | 2008 |
Risk indicators for development of headache during dipyridamole treatment after cerebral ischaemia of arterial origin.
Topics: Aged; Aspirin; Brain Ischemia; Cerebral Arteries; Dipyridamole; Drug Therapy, Combination; Female; H | 2009 |
Comparison of exercise electrocardiography, technetium-99m sestamibi single photon emission computed tomography, and dobutamine and dipyridamole echocardiography for detection of coronary artery disease in hypertensive women.
Topics: Cardiotonic Agents; Coronary Artery Disease; Diagnosis, Differential; Dipyridamole; Dobutamine; Echo | 2010 |
Diagnostic and prognostic value of Doppler echocardiographic coronary flow reserve in the left anterior descending artery in hypertensive and normotensive patients [corrected]..
Topics: Aged; Coronary Angiography; Coronary Circulation; Coronary Stenosis; Dipyridamole; Echocardiography, | 2011 |
Coronary microcirculation in essential hypertension: a quantitative myocardial contrast echocardiographic approach.
Topics: Adult; Case-Control Studies; Coronary Circulation; Dipyridamole; Echocardiography; Humans; Hypertens | 2002 |
Dipyridamole or dobutamine in arterial hypertension: are sensitivity and specificity the sole keywords?
Topics: Dipyridamole; Echocardiography, Stress; Humans; Hypertension; Prognosis; Sensitivity and Specificity | 2002 |
Safety and feasibility of dobutamine and dipyridamole stress echocardiography in hypertensive patients.
Topics: Aged; Arrhythmias, Cardiac; Dipyridamole; Echocardiography, Stress; Equipment Safety; Feasibility St | 2002 |
Plasma asymmetric dimethylarginine and hyperemic myocardial blood flow in young subjects with borderline hypertension or familial hypercholesterolemia.
Topics: Adult; Age Factors; Arginine; Biomarkers; Blood Flow Velocity; Case-Control Studies; Coronary Circul | 2002 |
Stress echocardiography for risk stratification of patients with chest pain and normal or slightly narrowed coronary arteries.
Topics: Age Factors; Aged; Chest Pain; Coronary Artery Disease; Dipyridamole; Disease-Free Survival; Echocar | 2002 |
Clinical, exercise electrocardiographic, and pharmacologic stress echocardiographic findings for risk stratification of hypertensive patients with chest pain.
Topics: Cardiotonic Agents; Chest Pain; Dipyridamole; Dobutamine; Echocardiography; Electrocardiography; Exe | 2003 |
Coronary microcirculation into different models of left ventricular hypertrophy-hypertensive and athlete's heart: a contrast echocardiographic study.
Topics: Adult; Blood Pressure; Case-Control Studies; Coronary Circulation; Diastole; Dipyridamole; Echocardi | 2003 |
[REHABILITATION IN HEART DISEASE].
Topics: Acenocoumarol; Dipyridamole; Electrocardiography; Geriatrics; Heart Defects, Congenital; Heart Disea | 1963 |
[CLINICO-EXPERIMENTAL STUDIES ON THE POSITIVE INOTROPIC EFFECT OF PERSANTIN].
Topics: Biomedical Research; Blood Pressure; Coronary Disease; Digitalis Glycosides; Dipyridamole; Drug Ther | 1964 |
Common carotid intima-media thickness is correlated with myocardial flow reserve in patients with coronary artery disease: a useful non-invasive indicator of coronary atherosclerosis.
Topics: Aged; Carotid Artery, Common; Case-Control Studies; Coronary Angiography; Coronary Artery Disease; C | 2004 |
Amlodipine and carvedilol prevent cytotoxicity in cortical neurons isolated from stroke-prone spontaneously hypertensive rats.
Topics: Amlodipine; Animals; Antioxidants; Carbazoles; Carvedilol; Cell Death; Cell Hypoxia; Cells, Cultured | 2004 |
[Coronary flow vasodilator reserve in patients with type 2 diabetes mellitus-associated arterial hypertension].
Topics: Coronary Artery Disease; Coronary Circulation; Diabetes Mellitus, Type 2; Dipyridamole; Echocardiogr | 2004 |
Coronary flow velocity reserve is diminished in hypertensive left ventricular hypertrophy.
Topics: Adult; Aged; Blood Flow Velocity; Case-Control Studies; Coronary Circulation; Coronary Vessels; Dipy | 2005 |
Positron emission tomographic evaluation of regulation of myocardial perfusion in physiological (elite athletes) and pathological (systemic hypertension) left ventricular hypertrophy.
Topics: Adult; Aged; Coronary Circulation; Coronary Vessels; Dipyridamole; Echocardiography; Female; Heart V | 2005 |
Noninvasive detection of silent coronary artery disease in patients with essential hypertension, alone or associated with type 2 diabetes mellitus, using dipyridamole stress 99mtechnetium-sestamibi myocardial perfusion imaging.
Topics: Aged; Coronary Artery Disease; Coronary Circulation; Diabetes Mellitus, Type 2; Dipyridamole; Exerci | 2006 |
Effect of left ventricular hypertension, ischemia and vasoactive drugs on the myocardial distribution of coronary flow.
Topics: Animals; Coronary Vessels; Dipyridamole; Electrocardiography; Heart; Heart Ventricles; Hypertension; | 1967 |
Treatment of cerebral ischemia.
Topics: Aspirin; Brain Ischemia; Carotid Arteries; Dicumarol; Dipyridamole; Endarterectomy; Heart Murmurs; H | 1981 |
Effects of duration and severity of arterial hypertension and cardiac hypertrophy on coronary vasodilator reserve.
Topics: Animals; Cardiomegaly; Coronary Circulation; Dipyridamole; Disease Models, Animal; Hypertension; Mal | 1982 |
[Therapy of peripheral arterial occlusive diseases. Round table conference].
Topics: Alprostadil; Angioplasty, Balloon; Anti-Bacterial Agents; Anticoagulants; Arterial Occlusive Disease | 1983 |
Reduction of coronary reserve: a mechanism for angina pectoris in patients with arterial hypertension and normal coronary arteries.
Topics: Adult; Angina Pectoris; Coronary Angiography; Coronary Circulation; Dipyridamole; Female; Humans; Hy | 1984 |
Significance of prostaglandins and thromboxane A2 for the mode of action of cardiovascular drugs.
Topics: Animals; Anti-Arrhythmia Agents; Aorta; Dipyridamole; Epoprostenol; Guinea Pigs; Heart; Humans; Hype | 1980 |
[Combined use of alpha- and beta-adrenergic blockers with vasodilators in hypertensive crises].
Topics: Adult; Dipyridamole; Droperidol; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Midd | 1982 |
For your stroke-prone patients: a guide to drug treatment.
Topics: Aged; Antihypertensive Agents; Aspirin; Brain Diseases; Cerebral Angiography; Cerebrovascular Disord | 1980 |
[Anti-platelet-aggregating action of dipyridamole administered by slow intravenous infusion].
Topics: Adult; Aged; Diabetes Mellitus; Dipyridamole; Female; Humans; Hypertension; Male; Middle Aged; Myoca | 1980 |
Determinants of exercise capacity in the hypertensive elderly--a study based on the assessment of cardiac reserve by dipyridamole radionuclide angiography.
Topics: Aged; Dipyridamole; Exercise Test; Exercise Tolerance; Female; Heart; Humans; Hypertension; Male; Mi | 1995 |
Effect of short-term cardiovascular conditioning and low-fat diet on myocardial blood flow and flow reserve.
Topics: Ammonia; Case-Control Studies; Cholesterol; Cholesterol, Dietary; Coronary Circulation; Coronary Dis | 1995 |
Hypertension and ischemic heart disease. Role of dipyridamole echocardiography test.
Topics: Adult; Aged; Dipyridamole; Echocardiography; Electrocardiography; Female; Humans; Hypertension; Male | 1994 |
Absence of defects in SPECT thallium-201 myocardial images in patients with systemic hypertension and left ventricular hypertrophy.
Topics: Case-Control Studies; Dipyridamole; Exercise Test; Heart; Humans; Hypertension; Hypertrophy, Left Ve | 1994 |
Effects of hypothyroidism and hypertension on myocardial perfusion and vascularity in rabbits.
Topics: Animals; Arterioles; Blood Pressure; Body Weight; Coronary Circulation; Coronary Vessels; Dipyridamo | 1993 |
Structural and functional alterations of the intramyocardial coronary arterioles in patients with arterial hypertension.
Topics: Angina Pectoris; Arterioles; Coronary Angiography; Coronary Circulation; Coronary Vessels; Dipyridam | 1993 |
Effects of dipyridamole in spontaneously hypertensive rabbits with diffuse chronic cerebral ischemia.
Topics: Analysis of Variance; Animals; Blood Pressure; Brain Ischemia; Cerebrovascular Circulation; Dipyrida | 1993 |
[Diagnostic value of myocardial thallium stress scintigraphy in the detection of coronary artery disease in patients undergoing chronic hemodialysis].
Topics: Adult; Aged; Coronary Angiography; Coronary Disease; Dipyridamole; Exercise Test; Female; Humans; Hy | 1995 |
In patients with hypertensive left ventricular hypertrophy and coronary heart disease, coronary flow reserve is similarly impaired.
Topics: Adult; Aged; Aminophylline; Blood Flow Velocity; Cardiotonic Agents; Coronary Circulation; Coronary | 1995 |
A case of hypertensive-diabetic cardiomyopathy demonstrating left ventricular wall motion abnormality.
Topics: Cardiomyopathies; Coronary Angiography; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dipyridamo | 1996 |
Macrovascular disease is associated with increased plasma apolipoprotein A-IV levels in NIDDM.
Topics: Apolipoproteins A; Biomarkers; Blood Glucose; Blood Pressure; Cerebrovascular Disorders; Cholesterol | 1997 |
A case of dermatomyositis complicated by thrombotic thrombocytopenic purpura.
Topics: Anti-Inflammatory Agents; Dermatomyositis; Dipyridamole; Dyspnea; Epoprostenol; Fatal Outcome; Fever | 1997 |
Mechanisms of coronary flow reserve impairment in human hypertension. An integrated approach by transthoracic and transesophageal echocardiography.
Topics: Adult; Aged; Angina Pectoris; Blood Flow Velocity; Blood Pressure; Cardiomegaly; Coronary Vessels; D | 1997 |
Technetium-99m sestamibi myocardial tomography based on dipyridamole echocardiography testing in hypertensive patients with chest pain.
Topics: Chest Pain; Coronary Angiography; Coronary Disease; Dipyridamole; Echocardiography; Electrocardiogra | 1997 |
Homogeneously reduced versus regionally impaired myocardial blood flow in hypertensive patients: two different patterns of myocardial perfusion associated with degree of hypertrophy.
Topics: Adult; Aged; Ammonia; Analysis of Variance; Chi-Square Distribution; Coronary Circulation; Coronary | 1998 |
Early impairment of coronary flow reserve in young men with borderline hypertension.
Topics: Adult; Blood Pressure Monitors; Coronary Circulation; Dipyridamole; Electrocardiography, Ambulatory; | 1998 |
Antiplatelet therapy decreases the incidence of erythropoietin-induced hypertension in predialysis patients.
Topics: Adult; Aged; Anemia; Dilazep; Dipyridamole; Erythropoietin; Female; Hematocrit; Humans; Hypertension | 1999 |
Prediction of cardiovascular events in clinically selected high-risk NIDDM patients. Prognostic value of exercise stress test and thallium-201 single-photon emission computed tomography.
Topics: Activities of Daily Living; Aged; Analysis of Variance; Cardiovascular Diseases; Cholesterol; Choles | 1999 |
Improvement of impaired myocardial vasodilatation due to diffuse coronary atherosclerosis in hypercholesterolemics after lipid-lowering therapy.
Topics: Aged; Coronary Artery Disease; Coronary Circulation; Coronary Vessels; Diabetes Mellitus; Dipyridamo | 1999 |
Comparison of stress/rest myocardial perfusion tomography, dipyridamole and dobutamine stress echocardiography for the detection of coronary disease in hypertensive patients with chest pain and positive exercise test.
Topics: Aged; Angina Pectoris; Cardiotonic Agents; Coronary Angiography; Coronary Circulation; Coronary Dise | 1999 |
Changes in prostacyclin, thromboxane A2 and F2-isoprostanes, and influence of eicosapentaenoic acid and antiplatelet agents in patients with hypertension and hyperlipidemia.
Topics: Aspirin; Dinoprost; Dipyridamole; Eicosapentaenoic Acid; Epoprostenol; Humans; Hyperlipidemias; Hype | 1999 |
Ischemic heart disease in black South African stroke patients.
Topics: Adult; Aged; Aged, 80 and over; Black People; Chest Pain; Comorbidity; Diabetes Mellitus; Dipyridamo | 2000 |
Coronary microangiopathy in type 2 diabetic patients: relation to glycemic control, sex, and microvascular angina rather than to coronary artery disease.
Topics: Adult; Aged; Blood Glucose; Coronary Angiography; Coronary Circulation; Coronary Disease; Diabetes M | 2000 |
Evaluation of coronary flow reserve in hypertensive patients by dipyridamole transesophageal doppler echocardiography.
Topics: Angina Pectoris; Blood Flow Velocity; Coronary Circulation; Coronary Disease; Diastole; Dipyridamole | 2000 |
Evaluation of coronary blood flow reserve by 13N-NH3 positron emission computed tomography (PET) with dipyridamole in the treatment of hypertension with the ACE inhibitor (Cilazapril).
Topics: Aged; Aged, 80 and over; Ammonia; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cilazapr | 2000 |
Dipyridamole-atropine stress echocardiography versus exercise SPECT scintigraphy for detection of coronary artery disease in hypertensives with positive exercise test.
Topics: Adult; Aged; Angiocardiography; Atropine; Coronary Disease; Dipyridamole; Echocardiography; Electroc | 2001 |
Prognostic value of dipyridamole stress echocardiography in hypertensive patients with left ventricular hypertrophy, chest pain and resting electrocardiographic repolarization abnormalities.
Topics: Aged; Chest Pain; Coronary Disease; Dipyridamole; Echocardiography; Electrocardiography; Electrophys | 2001 |
Stress echocardiography for risk stratification of diabetic patients with known or suspected coronary artery disease.
Topics: Adrenergic beta-Agonists; Age Factors; Aged; Coronary Disease; Diabetes Complications; Diabetes Mell | 2001 |
Attenuated myocardial vasodilator response in patients with hypertensive hypertrophy revealed by oxygenation-dependent magnetic resonance imaging.
Topics: Adult; Coronary Circulation; Coronary Vessels; Dipyridamole; Female; Humans; Hypertension; Hypertrop | 2001 |
[Echocardiographic evaluation of coronary flow reserve in patients with essential hypertension].
Topics: Coronary Circulation; Dipyridamole; Humans; Hypertension; Hypertrophy, Left Ventricular; Middle Aged | 2002 |
Location and clinical implications of high-degree atrioventricular block during dipyridamole infusion: a case report.
Topics: Aged; Dipyridamole; Electrocardiography; Female; Heart Block; Humans; Hypertension; Osteoarthritis; | 2002 |
Multiple progressive intracranial arterial occlusions ('moyamoya' disease).
Topics: Adrenal Cortex Hormones; Adult; Antihypertensive Agents; Arterial Occlusive Diseases; Cerebral Angio | 1977 |
Treatment of fetal growth retardation in utero with heparin and dipyridamole.
Topics: Dipyridamole; Female; Fetal Growth Retardation; Heparin; Humans; Hypertension; Placenta; Placental F | 1975 |
Prevention of stroke.
Topics: Age Factors; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Auscultation; Cerebral Angiograph | 1975 |
[Clinical and experimental results of treatment with amiodarone in coronary insufficiency].
Topics: Aged; Amiodarone; Angina Pectoris; Arrhythmias, Cardiac; Benzofurans; Coronary Disease; Dipyridamole | 1975 |
Failure of heparin therapy to affect the clinical course of severe pre-eclampsia.
Topics: Blood Cell Count; Blood Coagulation Tests; Blood Platelets; Dipyridamole; Disseminated Intravascular | 1975 |
[Hypertension and "silent" myocardial ischemia. I. The results of stress scintigraphy of the myocardium in patients].
Topics: Adult; Cardiac Pacing, Artificial; Coronary Artery Disease; Dipyridamole; Electrocardiography, Ambul | 1992 |
The effect of nifedipine and dipyridamole on the Doppler blood flow waveforms of umbilical and uterine arteries in hypertensive pregnant women.
Topics: Adult; Arteries; Blood Flow Velocity; Dipyridamole; Female; Humans; Hypertension; Nifedipine; Pregna | 1992 |
A negative thallium (+/- dipyridamole) stress test excludes significant obstructive epicardial coronary artery disease in hypertensive patients.
Topics: Adult; Cardiomegaly; Coronary Angiography; Coronary Disease; Dipyridamole; Echocardiography; Exercis | 1992 |
Anti-platelet therapy in diabetic and non-diabetic progressive renal failure.
Topics: Aspirin; Blood Pressure; Creatinine; Diabetic Nephropathies; Dipyridamole; Docosahexaenoic Acids; Dr | 1992 |
Increased prevalence of ventricular arrhythmias in essential hypertensives with dipyridamole-induced ischemic-like S-T segment changes.
Topics: Arrhythmias, Cardiac; Coronary Angiography; Coronary Disease; Dipyridamole; Echocardiography; Electr | 1991 |
Coronary circulation in arterial hypertension.
Topics: Animals; Coronary Circulation; Dipyridamole; Heart Failure; Humans; Hypertension; Middle Aged; Rats; | 1991 |
Dipyridamole decreases circulating renin-angiotensin system activity in hypertensive patients.
Topics: Adenosine; Administration, Oral; Adult; Aldosterone; Blood Pressure; Creatine; Dipyridamole; Female; | 1992 |
Dipyridamole echocardiography stress testing in hypertensive patients. Targets and tools.
Topics: Cardiomegaly; Coronary Disease; Dipyridamole; Echocardiography; Exercise; Humans; Hypertension; Micr | 1991 |
Relationship between coronary blood flow and perfusion pressure during reactive hyperemia: a case report in an awake unanesthetized woman with normal coronary arteries.
Topics: Aged; Blood Flow Velocity; Blood Pressure; Coronary Circulation; Dipyridamole; Echocardiography, Dop | 1991 |
Role of adenosine in functional hyperemia in skeletal muscle as indicated by pharmacological tools.
Topics: Adenosine; Administration, Topical; Animals; Arterioles; Dipyridamole; Dose-Response Relationship, D | 1991 |
Relations among impaired coronary flow reserve, left ventricular hypertrophy and thallium perfusion defects in hypertensive patients without obstructive coronary artery disease.
Topics: Cardiac Catheterization; Cardiomegaly; Coronary Circulation; Coronary Disease; Dipyridamole; Echocar | 1990 |
Silent myocardial ischemia and infarction in diabetics with peripheral vascular disease: assessment by dipyridamole thallium-201 scintigraphy.
Topics: Adult; Aged; Aged, 80 and over; Coronary Disease; Diabetes Complications; Diabetes Mellitus; Diabete | 1990 |
Drug-induced epistaxis?
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Coronary Disease; Dipyr | 1990 |
ST segment depression elicited by dipyridamole infusion in asymptomatic hypertensive patients.
Topics: Adult; Coronary Angiography; Dipyridamole; Echocardiography; Electrocardiography; Female; Humans; Hy | 1990 |
Cilazapril prevents the development of cardiac hypertrophy and the decrease of coronary vascular reserve in spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Cardiomegaly; Cilazapril; Coronary C | 1988 |
[Prevention of complications of severe arterial hypertension in pregnancy using platelet antiaggregants].
Topics: Adult; Aspirin; Dipyridamole; Drug Therapy, Combination; Female; Humans; Hypertension; Pregnancy; Pr | 1989 |
Clinical trials on the efficacy of pharmacologic intervention reducing mortality from cardiovascular diseases.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Aspirin; Cardiovascular Diseases; Clofibrate; | 1985 |
Dipyridamole-echocardiography test in essential hypertensives with chest pain and angiographically normal coronary arteries.
Topics: Angina Pectoris; Cardiomyopathy, Hypertrophic; Coronary Angiography; Coronary Disease; Dipyridamole; | 1989 |
Alterations in myocardial thallium-201 distribution in patients with chronic systemic hypertension undergoing single-photon emission computed tomography.
Topics: Cardiomegaly; Diagnosis, Differential; Dipyridamole; Echocardiography; Female; Heart; Humans; Hypert | 1988 |
Dipyridamole echocardiography in essential hypertensive patients with chest pain.
Topics: Angiography; Chest Pain; Coronary Disease; Dipyridamole; Echocardiography; Exercise Test; Feasibilit | 1988 |
[Reverse redistribution in dipyridamole-loading thallium-201 images using single photon emission computed tomography].
Topics: Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Diabetes Mellitus; Dipyridamole; Electrocardio | 1986 |
[Effect of corglycon and vasoactive agents on systemic and cerebral hemodynamics in cerebral infarct].
Topics: Aged; Cerebral Infarction; Cerebrovascular Circulation; Dipyridamole; Drug Evaluation; Female; Hemod | 1987 |
Reduced pulmonary arterial compliance in hypertensive pregnancy.
Topics: Adult; Blood Pressure; Capillaries; Cardiac Output; Dipyridamole; Elasticity; Electrocardiography; F | 1973 |
Arteritis with impaired renal function.
Topics: Adult; Aged; Anticoagulants; Azathioprine; Biopsy; Cyclophosphamide; Dipyridamole; Drug Therapy, Com | 1973 |
Influence of some drugs on platelet aggregation: a study in hypertensive patients.
Topics: Adenosine Diphosphate; Anti-Inflammatory Agents; Aspirin; Benzyl Compounds; Blood Cell Count; Blood | 1972 |
[Clinical pathophysiological studies on coronary circulation. 3. The effects of so-called coronary vasodilator agents on coronary circulation in various diseases].
Topics: Adolescent; Adult; Aged; Benzoates; Benzofurans; Blood Flow Velocity; Blood Pressure; Coronary Disea | 1971 |
Second phase platelet aggregation induced by adenosine diphosphate in patients with cerebral vascular disease and in control subjects.
Topics: Adenine Nucleotides; Adult; Aged; Blood Platelets; Bronchitis; Carpal Tunnel Syndrome; Cerebrovascul | 1970 |
On the factors which affect the immediate and long-term prognosis of myocardial infarction.
Topics: Adult; Age Factors; Aged; Angina Pectoris; Blood Pressure; Diabetes Complications; Dipyridamole; Ele | 1967 |
[On the protective action of coronary vessel collaterals].
Topics: Animals; Arteries; Collateral Circulation; Coronary Vessels; Dipyridamole; Hypertension; Hypoxia; Ra | 1967 |